Neither high-dose nor low-dose brachytherapy increases flap morbidity in salvage treatment of recurrent head and neck cancer

PURPOSE: While brachytherapy is often used concurrently with flap reconstruction following surgical ablation for head and neck cancer, it remains unclear whether it increases morbidity in the particularly high risk subset of patients undergoing salvage treatment for recurrent head and neck cancer (R...

Descripción completa

Detalles Bibliográficos
Autores principales: Henderson, Peter W., Kutler, David I., Parashar, Bhupesh, Otterburn, David M., Cohen, Marc A., Spector, Jason A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018532/
https://www.ncbi.nlm.nih.gov/pubmed/27648084
http://dx.doi.org/10.5114/jcb.2016.61976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018532/
https://www.ncbi.nlm.nih.gov/pubmed/27648084
http://dx.doi.org/10.5114/jcb.2016.61976

Ejemplares similares